Industry News

Industry News

Few Negative Reactions Expressed By Consumers To The Results Of Genetic Testing For Cancer Mutations

Feb 14, 2013

A 23andMe study of consumers' reactions to genetic testing found that even when the tests revealed high-risk mutations in individuals, those individuals had few negative reactions to the news. Instead of inducing serious anxiety, the test results prompted people to take positive steps, including follow-up visits with a doctor and discussions with family members who could also be at risk... Read More

Few Negative Reactions Expressed By Consumers To The Results Of Genetic Testing For Cancer Mutations

Feb 14, 2013

A 23andMe study of consumers' reactions to genetic testing found that even when the tests revealed high-risk mutations in individuals, those individuals had few negative reactions to the news. Instead of inducing serious anxiety, the test results prompted people to take positive steps, including follow-up visits with a doctor and discussions with family members who could also be at risk... Read More

Rise In Lung Cancer Deaths Among European Women

Feb 14, 2013

Lung cancer is likely to overtake breast cancer as the main cause of cancer death among European women by the middle of this decade, according to new research published in the cancer journal Annals of Oncology [1]. In the UK and Poland it has already overtaken breast cancer as the main cause of cancer deaths in women. The study by researchers in Italy and Switzerland predicts that just over 1... Read More

Possible Alternative Treatment To Significantly Reduce The Adverse Effects Of Chemotherapy In Lymphoid Leukemia

Feb 14, 2013

An international research team coordinated at the IRCM in Montréal found a possible alternative treatment for lymphoid leukemia. Led by Dr... Read More

Improved Understanding Of The Molecular Machinery Of Cancer

Feb 14, 2013

Researchers with Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley have provided important new details into the activation of the epidermal growth factor receptor (EGFR), a cell surface protein that has been strongly linked to a large number of cancers and is a major target of cancer therapies... Read More

Combining Synthetic, Natural Toxins Could Disarm Cancer, Drug-Resistant Bacteria

Feb 14, 2013

Cancer researchers from Rice University suggest that a new man-made drug that's already proven effective at killing cancer and drug-resistant bacteria could best deliver its knockout blow when used in combination with drugs made from naturally occurring toxins... Read More

African-American Women With Benign Breast Disease May Be At Greater Risk For Cancer

Feb 14, 2013

A Wayne State University researcher has identified characteristics in benign breast disease associated with future cancer risk in African-American women. Michele Cote, Ph.D... Read More

Possible Alternative Treatment To Significantly Reduce The Adverse Effects Of Chemotherapy In Lymphoid Leukemia

Feb 14, 2013

An international research team coordinated at the IRCM in Montréal found a possible alternative treatment for lymphoid leukemia. Led by Dr... Read More

Surveillance May Be Best For Small Kidney Tumors

Feb 13, 2013

Surveillance, or the watch and wait approach, may be the best option for older patients with small kidney tumors. The finding came from a large retrospective study which showed that surveillance is a safe alternative to surgery. The research will be presented at the American Society of Clinical Oncology (ASCO) conference on Saturday... Read More

NICE Issues Preliminary Guidance To Not Recommend Jakavi™ In The Treatment Of Rare Blood Cancer As Not Cost-Effective

Feb 13, 2013

Novartis today expressed disappointment at the National Institute for Health and Clinical Excellence's (NICE) preliminary recommendation to not recommend Jakavi™ (INC424, ruxolitinib) for the treatment of disease-related splenomegaly (enlarged spleen) or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycyth... Read More

Previous Page   Next Page